Seattle Genetics Inc. (SGEN) posted a fourth quarter loss of $12.1 million or $0.12 per share, compared to a loss of $30.6 million or $0.38 per share in the prior year quarter.
On average, ten analysts polled by Thomson Reuters expected the company to report a loss of $0.23 per share. Analysts' estimates typically exclude special items.
Revenues in the fourth quarter were $21.8 million, compared to $10.1 million in the previous year period. Nine Wall Street analysts expected revenues of $11.71 million.
Looking forward, for the fiscal year 2010, Seattle Genetics expects revenues to be in the range of $95 million to $105 million. Wall Street analysts expect revenues of $47.32 million.
For comments and feedback contact: editorial@rttnews.com
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.